Article Information
History
- August 12, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Shamez N Ladhani, MRCPCH(UK)1,2,*,
- Anna Jeffery-Smith, BMBCh3,
- Monika Patel, BSc3,
- Roshni Janarthanan, MBBS4,
- Jonathan Fok, FFPH4,
- Emma Crawley-Boevey, MFPH4,
- Amoolya Vusirikala, MPH4,
- Elena Fernandez, BSc.4,
- Marina Sanchez Perez, MPH4,
- Suzanne Tang, MPH4,
- Kate Dun-Campbell, MRCGP4,
- Edward Wynne-Evans, FFPH4,
- Anita Bell, FFPH4,
- Bharat Patel, FRCPath4,
- Zahin Amin-Chowdhury, BSc1,
- Felicity Aiano, MPH1,
- Karthik Paranthaman, FFPH5,
- Thomas Ma, MSc5,
- Maria Saavedra-Campos, MSc5,
- Joanna Ellis, PhD3,
- Meera Chand, FRCPath6,
- Kevin Brown, FRCPath3,
- Mary E Ramsay, FFPH1,
- Susan Hopkins6,
- Nandini Shetty, FRCPath3,
- J. Yimmy Chow, FFPH4,
- Robin Gopal, PhD3 and
- Maria Zambon, FRCPath3
- 1Immunisation and Countermeasures Division, Public Health England, London, UK
- 2Paediatric Infectious Diseases Research Group, St. George’s University of London, UK
- 3Virus Reference department, Public Health England, London, UK
- 4London Health Protection team, National Infection Service, Public Health England, London, UK
- 5Field Service, National Infection Service, Public Health England
- 6Antimicrobial Resistance and Hospital Acquired Infection Department, Public Health England, London, UK
- ↵*
Corresponding author:
Dr Shamez Ladhani, the Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom. Email: shamez.ladhani{at}phe.gov.uk
Posted August 12, 2020.
High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19; prospective cohort study, England
